To study the effect of anti-seizure drug named levetiracetam on body weight, blood pressure, blood cholesterol and blood sugar levels in adult patients having seizure disorder treated with levetiracetam.
- Conditions
- Health Condition 1: G403- Generalized idiopathic epilepsy and epileptic syndromes
- Registration Number
- CTRI/2023/01/048946
- Lead Sponsor
- Pt BD Sharma PGIMS Rohtak
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 70
1) Patients of =18 to = 40 years of age of either gender.
2) Patients with newly diagnosed epilepsy.
3) Patients/LAR willing to provide written informed consent.
1) Patients with Body mass index (BMI) = 30 kg/m2.
2) Patients with co-existing Type 2 Diabetes mellitus and/or Hypertension.
3) Patients with dyslipidemia who are already on lipid-lowering agents.
4) Patients on medication that are known to interfere with body weight status, such as antidepressants, corticosteroids, and anti-thyroid drugs.
5) Pregnant patients of epilepsy.
6) Patients with a history of alcohol/ substance abuse.
7) Patients having any personality or psychiatric disorders.
8) Patients having severe physical disability, thyroid, liver, or renal dysfunction.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method